Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Tumorigenic cancer stem cells (CSCs) are a distinct subpopulation driving tumor growth, metastasis, and relapse.
• CSCs possess unique self-renewal and differentiation properties, evading conventional therapies.
• Understanding CSC signaling is crucial for advancing cancer pathology and treatment.

Purpose of the Study:

• To review the origin and distinct signaling pathways of cancer stem cells (CSCs).
• To emphasize ligand-receptor interactions, upstream/downstream mechanisms, and associated molecules in CSC signaling.
• To explore CSC-associated signaling pathways as potential therapeutic targets and discuss recent advancements in CSC-based therapies.

Main Methods:

• Literature review focusing on CSC origin and associated signaling pathways.
• In-depth analysis of CSC signaling mechanisms, including ligand-receptor engagement and molecular players.
• Review of pre-clinical and clinical studies on novel CSC signaling pathway-targeted cancer therapeutics.

Main Results:

• CSCs exhibit unique genetic and phenotypic profiles and distinct signaling pathways.
• Key CSC signaling pathways include Wnt, TGFβ/SMAD, Notch, JAK-STAT, Hedgehog, and VEGF.
• Milestone discoveries in CSC-based therapies highlight the potential of targeting these pathways.

Conclusions:

• Targeting CSCs' unique properties and signaling pathways represents a significant breakthrough in cancer therapy.
• A comprehensive understanding of CSC signaling mechanisms is vital for developing effective cancer treatments.
• Novel CSC-based therapeutics targeting specific signaling pathways show promise in pre-clinical and clinical studies.